HomeASLN • NASDAQ
add
Aslan Pharmaceuticals Ltd
Previous close
$0.47
Day range
$0.45 - $0.49
Year range
$0.39 - $4.69
Market cap
10.37M USD
Avg Volume
1.04M
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 0.00 | — |
Operating expense | 12.85M | -4.08% |
Net income | -13.51M | 6.69% |
Net profit margin | — | — |
Earnings per share | -0.79 | 24.04% |
EBITDA | -12.84M | 4.10% |
Effective tax rate | -0.30% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 21.25M | -62.65% |
Total assets | 24.63M | -59.75% |
Total liabilities | 37.91M | -28.22% |
Total equity | -13.29M | — |
Shares outstanding | 22.63M | — |
Price to book | -0.62 | — |
Return on assets | -92.74% | — |
Return on capital | -125.99% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -13.51M | 6.69% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2010
Website
Employees
35